Scientific and Regulatory Policy Committee Points to Consider: Histopathologic Evaluation in Safety Assessment Studies for PEGylated Pharmaceutical Products.
Toxicol Pathol
; 46(6): 616-635, 2018 08.
Article
in En
| MEDLINE
| ID: mdl-30092727
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Policy Making
/
Polyethylene Glycols
/
Vacuoles
/
Pharmaceutical Preparations
/
Consumer Product Safety
/
Drug Evaluation, Preclinical
/
Drug-Related Side Effects and Adverse Reactions
Type of study:
Etiology_studies
/
Evaluation_studies
/
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
Toxicol Pathol
Year:
2018
Type:
Article
Affiliation country:
United States